Corrigendum :: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

Lorenz Kocheise; Ignazio Piseddu; Joscha Vonderlin; Eric T. Tjwa; Gustav Buescher; Lucy Meunier; Pia Goeggelmann; Francesca Fianchi; Jérôme Dumortier; Mar Riveiro Barciela; Tom J. G. Gevers; Benedetta Terziroli Beretta-Piccoli; Maria-Carlota Londoño; Sona Frankova; Thomas Roesner; Vincent Joerg; Constantin Schmidt; Fabian Glaser; Thorben W. Fründt; Ansgar W. Lohse; Samuel Huber; Johann von Felden; Marcial Sebode; Kornelius Schulze

doi:10.3389/fimmu.2024.1369747

Corrigendum : PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, Eric T. Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro Barciela, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Thorben W. Fründt, Ansgar W. LohseSamuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

2 Cites (Scopus)

Idioma original	Anglès
Revista	Frontiers in Immunology
Volum	15
DOIs	https://doi.org/10.3389/fimmu.2024.1369747
Estat de la publicació	Publicada - 2024

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Accés al document

10.3389/fimmu.2024.1369747

https://ddd.uab.cat/record/307588

Altres arxius i enllaços

https://www.scopus.com/pages/publications/85184423942

Com citar-ho

Kocheise, L., Piseddu, I., Vonderlin, J., Tjwa, E. T., Buescher, G., Meunier, L., Goeggelmann, P., Fianchi, F., Dumortier, J., Riveiro Barciela, M., Gevers, T. J. G., Terziroli Beretta-Piccoli, B., Londoño, M.-C., Frankova, S., Roesner, T., Joerg, V., Schmidt, C., Glaser, F., Fründt, T. W., ... Schulze, K. (2024). Corrigendum : PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1369747

@article{e2b389c53c0c4f8b998988a06f2d8a98,

title = "Corrigendum :: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease",

keywords = "Autoimmune disease (AID), Immune checkpoint inhibitors (ICI), Autoimmune liver diseases (AILD), Immune related adverse effects (irAEs), PD-1/PD-L1 immune checkpoint inhibitors, Autoimmune hepatitis (AIH), Primary sclerosing cholangites (PSC), Primary biliary cholangitis (PBC)",

author = "Lorenz Kocheise and Ignazio Piseddu and Joscha Vonderlin and Tjwa, \{Eric T.\} and Gustav Buescher and Lucy Meunier and Pia Goeggelmann and Francesca Fianchi and J{\'e}r{\^o}me Dumortier and \{Riveiro Barciela\}, Mar and Gevers, \{Tom J. G.\} and \{Terziroli Beretta-Piccoli\}, Benedetta and Maria-Carlota Londo{\~n}o and Sona Frankova and Thomas Roesner and Vincent Joerg and Constantin Schmidt and Fabian Glaser and Fr{\"u}ndt, \{Thorben W.\} and Lohse, \{Ansgar W.\} and Samuel Huber and \{von Felden\}, Johann and Marcial Sebode and Kornelius Schulze",

year = "2024",

doi = "10.3389/fimmu.2024.1369747",

language = "English",

volume = "15",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

Kocheise, L, Piseddu, I, Vonderlin, J, Tjwa, ET, Buescher, G, Meunier, L, Goeggelmann, P, Fianchi, F, Dumortier, J, Riveiro Barciela, M, Gevers, TJG, Terziroli Beretta-Piccoli, B, Londoño, M-C, Frankova, S, Roesner, T, Joerg, V, Schmidt, C, Glaser, F, Fründt, TW, Lohse, AW, Huber, S, von Felden, J, Sebode, M & Schulze, K 2024, 'Corrigendum : PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease', Frontiers in Immunology, vol. 15. https://doi.org/10.3389/fimmu.2024.1369747

TY - JOUR

T1 - Corrigendum :

T2 - PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

AU - Kocheise, Lorenz

AU - Piseddu, Ignazio

AU - Vonderlin, Joscha

AU - Tjwa, Eric T.

AU - Buescher, Gustav

AU - Meunier, Lucy

AU - Goeggelmann, Pia

AU - Fianchi, Francesca

AU - Dumortier, Jérôme

AU - Riveiro Barciela, Mar

AU - Gevers, Tom J. G.

AU - Terziroli Beretta-Piccoli, Benedetta

AU - Londoño, Maria-Carlota

AU - Frankova, Sona

AU - Roesner, Thomas

AU - Joerg, Vincent

AU - Schmidt, Constantin

AU - Glaser, Fabian

AU - Fründt, Thorben W.

AU - Lohse, Ansgar W.

AU - Huber, Samuel

AU - von Felden, Johann

AU - Sebode, Marcial

AU - Schulze, Kornelius

PY - 2024

Y1 - 2024

KW - Autoimmune disease (AID)

KW - Immune checkpoint inhibitors (ICI)

KW - Autoimmune liver diseases (AILD)

KW - Immune related adverse effects (irAEs)

KW - PD-1/PD-L1 immune checkpoint inhibitors

KW - Autoimmune hepatitis (AIH)

KW - Primary sclerosing cholangites (PSC)

KW - Primary biliary cholangitis (PBC)

UR - https://www.scopus.com/pages/publications/85184423942

U2 - 10.3389/fimmu.2024.1369747

DO - 10.3389/fimmu.2024.1369747

M3 - Article

C2 - 38327519

SN - 1664-3224

VL - 15

JO - Frontiers in Immunology

JF - Frontiers in Immunology

ER -